PubMed for id: 2740

Year	Number of Results
1993	4
1994	4
1995	2
1997	1
1999	1
2000	3
2002	3
2003	1
2004	4
2005	4
2006	2
2007	2
2008	7
2009	10
2010	18
2011	16
2012	11
2013	9
2014	20
2015	26
2016	48
2017	18
2018	28
2019	16
2020	17
2021	15
2022	15
2023	16
2024	3

1

The role of G protein-coupled receptor kinases in GLP-1R β-arrestin recruitment and internalisation.

McNeill SM, Lu J, Marion C Carino C, Inoue A, Zhao P, Sexton PM, Wootten D. McNeill SM, et al. Biochem Pharmacol. 2024 Apr;222:116119. doi: 10.1016/j.bcp.2024.116119. Epub 2024 Mar 8. Biochem Pharmacol. 2024. PMID: 38461904 Free article.

2

A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS.

Bader S, Bhatti R, Mussa B, Abusanana S. Bader S, et al. Womens Health (Lond). 2024 Jan-Dec;20:17455057241234530. doi: 10.1177/17455057241234530. Womens Health (Lond). 2024. PMID: 38444070 Free PMC article. Review.

3

Polymorphisms in the glucagon-like peptide-1 receptor gene and their interactions on the risk of osteoporosis in postmenopausal Chinese women.

Liu C, Bao X, Tian Y, Xue P, Wang Y, Li Y. Liu C, et al. PLoS One. 2023 Dec 14;18(12):e0295451. doi: 10.1371/journal.pone.0295451. eCollection 2023. PLoS One. 2023. PMID: 38096145 Free PMC article.

4

Integrated genetic and epigenetic analyses uncovered GLP1R association with metabolically healthy obesity.

Han F, Zhu S, Kong X, Wang W, Wu Y. Han F, et al. Int J Obes (Lond). 2024 Mar;48(3):324-329. doi: 10.1038/s41366-023-01414-1. Epub 2023 Nov 17. Int J Obes (Lond). 2024. PMID: 37978261

5

Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas.

Vesterinen T, Peltola E, Leijon H, Hannula P, Huhtala H, Mäkinen MJ, Nieminen L, Pirinen E, Rönty M, Söderström M, Jaatinen P, Arola J. Vesterinen T, et al. Int J Mol Sci. 2023 Oct 13;24(20):15164. doi: 10.3390/ijms242015164. Int J Mol Sci. 2023. PMID: 37894845 Free PMC article.

6

Glucagon-like peptide-1 receptor blockade impairs islet secretion and glucose metabolism in humans.

Welch AA, Farahani RA, Egan AM, Laurenti MC, Zeini M, Vella M, Bailey KR, Cobelli C, Dalla Man C, Matveyenko A, Vella A. Welch AA, et al. J Clin Invest. 2023 Nov 15;133(22):e173495. doi: 10.1172/JCI173495. J Clin Invest. 2023. PMID: 37751301 Free PMC article.

7

Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity.

Gao W, Liu L, Huh E, Gbahou F, Cecon E, Oshima M, Houzé L, Katsonis P, Hegron A, Fan Z, Hou G, Charpentier G, Boissel M, Derhourhi M, Marre M, Balkau B, Froguel P, Scharfmann R, Lichtarge O, Dam J, Bonnefond A, Liu J, Jockers R. Gao W, et al. Nat Metab. 2023 Oct;5(10):1673-1684. doi: 10.1038/s42255-023-00889-6. Epub 2023 Sep 14. Nat Metab. 2023. PMID: 37709961

8

A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12).

Nakhleh A, Goldenberg-Furmanov M, Goldstein R, Shohat M, Shehadeh N. Nakhleh A, et al. J Diabetes Complications. 2023 Sep;37(9):108566. doi: 10.1016/j.jdiacomp.2023.108566. Epub 2023 Jul 28. J Diabetes Complications. 2023. PMID: 37536118

9

Association between GLP-1R gene polymorphism and dyslipidemia in Chinese patients with type 2 diabetes mellitus: A case-control study.

Li Y, Yang Z, Ren S, Shen B, Zhang Y, Zong H, Li Y. Li Y, et al. Gene. 2023 Aug 20;878:147589. doi: 10.1016/j.gene.2023.147589. Epub 2023 Jun 24. Gene. 2023. PMID: 37364698 Free article.

10

After GLP-1, what's next for weight loss?

Senior M. Senior M. Nat Biotechnol. 2023 Jun;41(6):740-743. doi: 10.1038/s41587-023-01818-4. Nat Biotechnol. 2023. PMID: 37280436 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

286 results

Results by year